Genetic susceptibility to tobacco carcinogenesis
- PMID: 10592771
- DOI: 10.3109/07357909909032849
Genetic susceptibility to tobacco carcinogenesis
Abstract
Lung cancer risk is thus defined by the balance between metabolic activation and detoxification of xenobiotic compounds and by the efficiency of DNA repair. It is most likely that multiple susceptibility factors must be accounted for to represent the true dimensions of gene-environment interactions. The ability to identify smokers with the highest risks of developing cancer has substantial preventive implications. These subgroups could be targeted for the most intensive screening and smoking cessation interventions and could be enrolled into chemoprevention trials. Studying susceptibility to common cancers and widely prevalent exposures may provide further insights into the basic mechanisms of carcinogenesis. Issues that will need to be addressed in the very near future include risk communication to study subjects and the ethical, legal, and social consequences of such testing.
Comment in
-
Additional clues to lung cancer risk.Cancer Invest. 1999;17(8):661-2. doi: 10.3109/07357909909032851. Cancer Invest. 1999. PMID: 10592773 No abstract available.
Similar articles
-
Genetic polymorphisms and lung cancer susceptibility: a review.Lung Cancer. 2002 Sep;37(3):241-56. doi: 10.1016/s0169-5002(02)00107-1. Lung Cancer. 2002. PMID: 12234692 Review.
-
Genetic polymorphism of CYP genes, alone or in combination, as a risk modifier of tobacco-related cancers.Cancer Epidemiol Biomarkers Prev. 2000 Jan;9(1):3-28. Cancer Epidemiol Biomarkers Prev. 2000. PMID: 10667460 Review.
-
Is there a genetic basis for lung cancer susceptibility?Recent Results Cancer Res. 1999;151:3-12. doi: 10.1007/978-3-642-59945-3_1. Recent Results Cancer Res. 1999. PMID: 10337715 Review.
-
Chemoprevention of lung cancer.Lung Cancer. 2001 Dec;34 Suppl 3:S91-4. doi: 10.1016/s0169-5002(01)00380-4. Lung Cancer. 2001. PMID: 11741000 Review.
-
Genetic susceptibility for lung cancer: interactions with gender and smoking history and impact on early detection policies.Hum Hered. 2003;56(1-3):139-45. doi: 10.1159/000073742. Hum Hered. 2003. PMID: 14614248
Cited by
-
Suppressing the activation of protein kinase A as a DNA damage-independent mechanistic lead for dihydromethysticin prophylaxis of NNK-induced lung carcinogenesis.Carcinogenesis. 2022 Aug 30;43(7):659-670. doi: 10.1093/carcin/bgac031. Carcinogenesis. 2022. PMID: 35353881 Free PMC article.
-
Differences in trends of lung carcinoma by histology type in Israeli Jews and Arabs, 1981-1995.Eur J Epidemiol. 2001;17(1):11-8. doi: 10.1023/a:1010916325886. Eur J Epidemiol. 2001. PMID: 11523571
-
Characterization of adductomic totality of NNK, (R)-NNAL and (S)-NNAL in A/J mice, and their correlations with distinct lung carcinogenicity.Carcinogenesis. 2022 Mar 24;43(2):170-181. doi: 10.1093/carcin/bgab113. Carcinogenesis. 2022. PMID: 34919675 Free PMC article.
-
Chronic immune activation and inflammation as the cause of malignancy.Br J Cancer. 2001 Aug 17;85(4):473-83. doi: 10.1054/bjoc.2001.1943. Br J Cancer. 2001. PMID: 11506482 Free PMC article. Review.
-
gammaH2AX: A potential DNA damage response biomarker for assessing toxicological risk of tobacco products.Mutat Res. 2009 Aug;678(1):43-52. doi: 10.1016/j.mrgentox.2009.06.009. Epub 2009 Jul 8. Mutat Res. 2009. PMID: 19591958 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
